Progress, Promise, & Placebos - Why IMRP May Be Underestimated
No ratings
When it rains it pours, but that can be a good thing when it comes to investments many of you may own. We've got a salvo of great news to get through today, with the highlight coming from a name we haven't looked at in a while - Immune Response Corporatio